In contrast to drug-sensitive tuberculosis , the guidelines for the treatment of multi-drug-resistant tuberculosis ( MDR-TB ) have a very poor evidence base ; current recommendations , based on expert opinion , are that patients should be treated for a minimum of 20 months .